Medical News

RSS

AAN, Wolters Kluwer Health announce launch of Neurology Today for the iPad

The American Academy of Neurology (AAN) and Wolters Kluwer Health today announced the launch of Neurology Today for the iPad, a digital app of the most widely read newspaper for neurologists.

10 Jan 2012

RUMC moves 200 patients into new 14-story hospital building

After more than seven years of planning and three years of construction, Rush University Medical Center successfully moved approximately 200 patients into the Tower, Rush's new, 14-story, state-of-the-art hospital building, located at Ashland Avenue and the Eisenhower Expressway.

10 Jan 2012

DHA plays an essential role in creating healthy sperm

Who knew that male fertility depends on sperm-cell architecture? A University of Illinois study reports that a certain omega-3 fatty acid is necessary to construct the arch that turns a round, immature sperm cell into a pointy-headed super swimmer with an extra long tail.

10 Jan 2012

Insulin induces formation of new elastin in cultures of human aortic smooth muscle cells

New research reveals that insulin applied in therapeutic doses selectively stimulates the formation of new elastic fibers in cultures of human aortic smooth muscle cells.

10 Jan 2012

Roundup: Iowa weighs mental health care changes; Ariz. clinic seeks to cut ER costs

Republican and Democratic legislators and Gov. Terry Branstad have said they want to reform Iowa's mental health system to reduce waiting lists and provide more equitable services. Currently, each of Iowa's counties performs or contracts for mental health services for indigent residents. Critics contend the 99-county system has led to pockets of inferior, inequitable service, particularly in rural areas.

10 Jan 2012

Life Technologies takes orders for new benchtop Ion Proton Sequencer

Life Technologies Corporation today announced it is taking orders for the new benchtop Ion Proton Sequencer that is designed to sequence the entire human genome in a day for $1,000.

10 Jan 2012

Amylin outlines key strategic priorities for 2012

Amylin Pharmaceuticals, Inc. today outlined its key strategic priorities for 2012, with a strong focus on driving the global commercial value of its diabetes franchise.

10 Jan 2012

Nicotine patch may boost memory in individuals with MCI

Wearing a nicotine patch may help improve memory loss in older adults with mild cognitive impairment, according to a study published today in Neurology, the medical journal of the American Academy of Neurology.

10 Jan 2012

CNBG, Aeras reach final agreement to develop new TB vaccines

The global fight against the tuberculosis epidemic receives a boost today as Aeras and the China National Biotec Group (CNBG) announce that they have reached final agreement to jointly develop new tuberculosis (TB) vaccines.

10 Jan 2012

Fallujah doctors say chemicals from U.S. weapons to blame for high levels of birth defects

"While the U.S. military has formally withdrawn from Iraq, doctors and residents of Fallujah are blaming weapons like depleted uranium and white phosphorous used during two devastating U.S. attacks on Fallujah in 2004 for what are being described as 'catastrophic' levels of birth defects and abnormalities," Al Jazeera reports.

10 Jan 2012

Researchers uncover exact function of LARGE enzyme linked with MD

Researchers at the University of Iowa have worked out the exact function of an enzyme that is critical for normal muscle structure and is involved in several muscular dystrophies. The findings, which were published Jan. 6 in the journal Science,, could be used to develop rapid, large-scale testing of potential muscular dystrophy therapies.

10 Jan 2012

Wolters Kluwer Health announces release of Oncology Times app for the iPad

Wolters Kluwer Health announced today the release of Oncology Times app for the iPad. Now cancer care professionals and others can access the latest oncology news and trends with the dynamic new Oncology Times app. Oncology Times is published by Lippincott Williams & Wilkins (LWW), part of Wolters Kluwer Health.

10 Jan 2012

Study identifies netrin-1 as novel target for atherosclerosis

A new study by NYU Langone Medical Center researchers identified a new culprit that leads to atherosclerosis, the accumulation of fat and cholesterol that hardens into plaque and narrows arteries. The research, published online by Nature Immunology on January 8, 2012, explains why cholesterol-laden, coronary artery disease-causing cells called macrophages, accumulate in artery plaques.

10 Jan 2012

Noise-cancelling headphones may reduce pain and anxiety of prostate biopsy

Tuning in to tune out may be just what's needed for men undergoing a prostate biopsy, according to researchers at the Duke Cancer Institute. The Duke team found that noise-cancelling headphones playing a classical melody may reduce the pain and anxiety of the often uncomfortable procedure.

9 Jan 2012

Political turmoil in Yemen causing breakdown of social services, increased threats to child welfare

"Yemen's populist uprising and the political crisis that followed have pushed the country to the brink of a humanitarian emergency, according to the United Nations and aid agencies," the Washington Post reports, noting that "children have been hit especially hard."

9 Jan 2012

USPTO issues patent to Lixte's lead compounds for treatment of neurological diseases

Lixte Biotechnology Holdings announces that the United States Patent and Trademark Office awarded a patent for the use of lead compounds from each of two different types of drugs, protein phosphatase inhibitors and histone deacetylase inhibitors, for the potential prevention and treatment of neurodegenerative diseases.

9 Jan 2012

JHM, Healthways partner for innovative weight-loss program

Building on the success of recent Hopkins research showing obese participants were able to lose significant weight and keep it off for two years using telephone coaching and a specially designed website, Johns Hopkins Medicine is collaborating with Healthways to help bring the innovative weight-loss program to many more who could benefit from it.

9 Jan 2012

Neomatrix, UND partner to develop technology for early detection of breast cancer

The University of North Dakota and Neomatrix, LLC, have signed an exclusive agreement to develop technology for the early detection of breast cancer using the company's HALO Breast Pap Test device.

9 Jan 2012

Mylan confirms Actoplus Met XR patent challenge

Mylan Inc. today confirmed that the company has been sued by Takeda Pharmaceutical Company, Watson Pharmaceuticals and Andrx Labs in connection with the filing of an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) for Pioglitazone Hydrochloride and Extended-release Metformin Hydrochloride tablets, 15 mg/1000 mg and 30 mg/1000 mg.

9 Jan 2012

Positive interim data from Idenix IDX184 12-week phase IIb trial on HCV

Idenix Pharmaceuticals, Inc., a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases, today announced interim data from a 12-week phase IIb clinical trial of IDX184, the Company's lead product candidate for the treatment of hepatitis C virus (HCV) infection.

9 Jan 2012